- Home
- NMTC vs FGEN Comparison
NMTC vs FGEN Comparison
Compare NMTC & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- FGEN
- Stock Information
- Founded
- NMTC 2009
- FGEN 1993
- Country
- NMTC United States
- FGEN United States
- Employees
- NMTC N/A
- FGEN N/A
- Industry
- NMTC Medical/Dental Instruments
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- FGEN Health Care
- Exchange
- NMTC Nasdaq
- FGEN Nasdaq
- Market Cap
- NMTC 33.8M
- FGEN 33.5M
- IPO Year
- NMTC N/A
- FGEN 2014
- Fundamental
- Price
- NMTC $0.73
- FGEN $7.69
- Analyst Decision
- NMTC Strong Buy
- FGEN Strong Buy
- Analyst Count
- NMTC 1
- FGEN 1
- Target Price
- NMTC $1.45
- FGEN $250.00
- AVG Volume (30 Days)
- NMTC 181.0K
- FGEN 74.7K
- Earning Date
- NMTC 08-13-2025
- FGEN 08-05-2025
- Dividend Yield
- NMTC N/A
- FGEN N/A
- EPS Growth
- NMTC N/A
- FGEN N/A
- EPS
- NMTC N/A
- FGEN N/A
- Revenue
- NMTC $5,758,777.00
- FGEN $6,996,000.00
- Revenue This Year
- NMTC $157.28
- FGEN N/A
- Revenue Next Year
- NMTC $41.79
- FGEN N/A
- P/E Ratio
- NMTC N/A
- FGEN N/A
- Revenue Growth
- NMTC 54.53
- FGEN N/A
- 52 Week Low
- NMTC $0.40
- FGEN $4.50
- 52 Week High
- NMTC $1.39
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- NMTC 60.04
- FGEN 63.73
- Support Level
- NMTC $0.71
- FGEN $5.37
- Resistance Level
- NMTC $0.77
- FGEN $5.73
- Average True Range (ATR)
- NMTC 0.05
- FGEN 0.51
- MACD
- NMTC 0.00
- FGEN 0.32
- Stochastic Oscillator
- NMTC 65.90
- FGEN 97.26
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.